Lori Beth Chibnik, PHD
Adjunct Assistant Professor, Biostatistics - Boston University School of Public Health
Biography
Dr. Lori Chibnik, PhD, MPH is a biostatistician and Adjunct Assistant Professor at the Boston University School of Public Health as well as Assistant Professor with a joint appointment in the Department of Epidemiology at the Harvard T.H. Chan School of Public Health and the Department of Medicine at the Harvard Medical School. She received her MPH in International Health and her PhD in biostatistics from Boston University where she worked on predictive modeling methods for disease risk. Over her career, she has developed and assessed predictive models for diseases such as HIV, prenatal screening, and autoimmune diseases and continues to apply her methods to various diseases. Dr. Chibnik’s current research focuses primarily on genetics and genomics of Alzheimer’s disease and dementia with an emphasis on longitudinal cohorts. In addition to her research, she is internationally renowned for her training programs and innovative teaching techniques, having developed multiple courses in biostatistics for varied audiences. While at Boston University she managed the Summer Institute for Training in Biostatistics, an NHLBI funded, 6-week summer program designed to bring undergraduate students into the fields of Biostatistics and Public Health. Most recently she developed and implemented a series of biostatistics and programming courses specific to the needs of scientists in sub-Saharan Africa. Currently, she directs the Global Initiative for Neuropsychiatric Genetics Education in Researcher at the Harvard-Chan School and the Stanley Center for Psychiatric Research in the Broad Institute of Harvard and MIT.
Education
- Boston University School of Public Health, PhD Field of Study: Biostatistics
- Boston University School of Public Health, MPH Field of Study: Epidemiology
- University of Wisconsin Madison, BS Field of Study: Physiology
Publications
- Published on 3/5/2026
Reynolds CA, Chen JT, Chakraborty P, Chibnik LB, Rich-Edwards JW, Charlton BM. Covariate adjustment in LGBTQ+ health disparities research: aligning methods with assumptions. Am J Epidemiol. 2026 Mar 05; 195(3):634-643. PMID: 40916718.
Read At: PubMed
- Published on 1/29/2026
Kivisäkk P, Fatima H, Wu CY, Padmanabhan N, Romero D, Gorham T, Weik M, Dodge HH, Scherzer CR, Das S, Chibnik LB, Blacker DL, Gomez-Isla T, Oakley DH, Frosch MP, Hyman BT, Demos C, Sigal G, Wohlstadter JN, Serrano-Pozo A, Arnold SE. Postmortem Associations Between Alzheimer Disease Pathology and Plasma pTau217, GFAP, and NfL in AD and AD-Related Dementias. Neurology. 2026 Feb 24; 106(4):e214351. PMID: 41610380.
Read At: PubMed
- Published on 1/5/2026
Leung WCY, Tanaka T, Donahue RA, Chan KCW, Wang J, Chung THF, Wong YK, Liu KCR, Leung IYH, Ho RW, Chu FHN, Leung AKL, Teo KC, Pang SYY, Yip EK, Ihara M, Fukuma K, Reeder HT, Chibnik LB, Cole AJ, Lau GKK, Singhal AB. Development and International Validation of a Novel Imaging-Based Risk Score (IsCHEMiA) for the Prediction of Poststroke Epilepsy. Neurology. 2026 Jan 27; 106(2):e214486. PMID: 41490217.
Read At: PubMed
- Published on 11/29/2025
Lam AD, Johnson EL, Sarkis RA, Blank LJ, Gaston TE, Shafi MM, Zepeda R, Pellerin KR, Jette N, Greve DN, Chibnik LB, Amariglio RE, Marshall GA, Westover MB. Late-onset unexplained epilepsy as a risk factor for cognitive impairment and dementia: Protocol for a multi-center prospective longitudinal observational study (ELUCID). Epilepsia Open. 2026 Feb; 11(1):363-375. PMID: 41317246.
Read At: PubMed
- Published on 11/14/2025
Liu J, Ratanatharathorn A, Yaskolka Meir A, Murchland AR, Zhu Y, Roberts AL, Lawn RB, Sumner JA, Haneuse S, Liang L, Kubzansky LD, Koenen KC, Chibnik LB. Corrigendum to "Posttraumatic stress disorder and epigenetic signatures of inflammation in middle-aged women" [Psychoneuroendocrinology 182 (2025) 107654]. Psychoneuroendocrinology. 2026 Feb; 184:107687. PMID: 41240613.
Read At: PubMed
- Published on 8/26/2025
Krivickas B, Scirocco E, Giacomelli E, Sharma S, Benson M, Keegan M, Kulesa-Kelley J, Chibnik LB, Casagrande G, Heyd L, Chase M, Drake K, Mohapatra S, Hagar JL, Hasenoehrl MG, Dagostino D, Sherman AV, Leite A, Yu H, Rosenthal J, Miller T, McCaffrey A, Gwathmey K, Locatelli E, Bayat E, Heitzman D, Young E, Goyal NA, Whitesell J, Felice K, Ilieva H, Swenson A, Walk D, Alameda G, Foster L, McIlduff CE, Walsh A, Zilliox L, Ajroud-Driss S, Bodkin C, Katz J, Ladha S, Rivner M, Rosow L, Twydell P, Wasiewski W, Babu S, Berry JD, Paganoni S. Multicenter Expanded Access Protocol for Research Through Access to Trehalose in People With Amyotrophic Lateral Sclerosis. Muscle Nerve. 2025 Nov; 72(5):1108-1116. PMID: 40857020.
Read At: PubMed
- Published on 7/8/2025
Yaskolka Meir A, Yun H, Hu J, Li J, Liu J, Bever A, Ratanatharathorn A, Song M, Eliassen AH, Chibnik L, Koenen K, Pare G, Stampfer MJ, Liang L. Cross-omics risk scores of inflammation markers are associated with all-cause mortality: The Canadian Longitudinal Study on Aging. Am J Hum Genet. 2025 Aug 07; 112(8):1892-1905. PMID: 40633542.
Read At: PubMed
- Published on 6/27/2025
Petrozziello T, Mizerak E, Krishnamoorthy A, Donahue RA, Castillo Torres AL, Monsanto RZB, Hammerschlag BL, Fillingham B, Kivisäkk P, Timmons J, Fox K, Arnold SE, Cohen J, Klee J, Paganoni S, Cudkowicz ME, Chibnik LB, Berry JD, Sadri-Vakili G. Plasma tau and phosphorylated tau at T181 are altered in amyotrophic lateral sclerosis. medRxiv. 2025 Jun 27. PMID: 40666341.
Read At: PubMed
- Published on 6/17/2025
Lam AD, Johnson EL, Sarkis RA, Blank LJ, Gaston TE, Shafi MM, Zepeda R, Pellerin KR, Jette N, Greve DN, Chibnik LB, Amariglio RE, Marshall GA, Westover MB. Late-onset unexplained epilepsy as a risk factor for cognitive impairment and dementia: Protocol for a multi-center prospective longitudinal observational study (ELUCID). medRxiv. 2025 Jun 17. PMID: 40585165.
Read At: PubMed
- Published on 5/27/2025
Gross RS, Thaweethai T, Salisbury AL, Kleinman LC, Mohandas S, Rhee KE, Snowden JN, Tantisira KG, Warburton D, Wood JC, Kinser PA, Milner JD, Rosenzweig EB, Irby K, Flaherman VJ, Karlson EW, Chibnik LB, Pant DB, Krishnamoorthy A, Gallagher R, Lamendola-Essel MF, Hasson DC, Katz SD, Yin S, Dreyer BP, Blancero F, Carmilani M, Coombs K, Fitzgerald ML, Letts RJ, Peddie AK, Aschner JL, Atz AM, Banerjee D, Bogie A, Bukulmez H, Clouser K, Cottrell LA, Cowan K, D'Sa VA, Dozor A, Elliott AJ, Faustino EVS, Fiks AG, Gaur S, Gennaro ML, Gordon S, Hasan UN, Hester CM, Hogan A, Hsia DS, Kaelber DC, Kosut JS, Krishnan S, McCulloh RJ, Michelow IC, Nolan SM, Oliveira CR, Olson LM, Pace WD, Palumbo P, Raissy H, Reyes A, Ross JL, Salazar JC, Selvarangan R, Stein CR, Stevenson MD, Teufel RJ, Werzberger A, Westfall JM, Zani K, Zempsky WT, Zimmerman E, Bind MC, Chan J, Guan Z, Morse RE, Reeder HT, Metz TD, Newburger JW, Truong DT, Foulkes AS, Stockwell MS. Characterizing Long COVID Symptoms During Early Childhood. JAMA Pediatr. 2025 May 27; 179(7):781-92. PMID: 40554463.
Read At: PubMed
View 187 more publications:View Full Profile at BUMC